I. Yu. Vizel

ORCID: 0000-0002-8855-8177
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sarcoidosis and Beryllium Toxicity Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Inhalation and Respiratory Drug Delivery
  • Sinusitis and nasal conditions
  • Healthcare Systems and Public Health
  • Respiratory and Cough-Related Research
  • Bacillus and Francisella bacterial research
  • Human Health and Disease
  • SARS-CoV-2 and COVID-19 Research
  • Drug-Induced Adverse Reactions
  • Respiratory Support and Mechanisms
  • Rheumatoid Arthritis Research and Therapies
  • Pediatric health and respiratory diseases
  • Neonatal Respiratory Health Research
  • COVID-19 Clinical Research Studies
  • Autoimmune and Inflammatory Disorders
  • Antibiotics Pharmacokinetics and Efficacy
  • Pneumonia and Respiratory Infections
  • Long-Term Effects of COVID-19
  • Lymphadenopathy Diagnosis and Analysis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Dermatological and COVID-19 studies
  • Economic, Social, and Public Health Issues in Russia and Globally

Kazan State Medical University
2015-2024

Ministry of Health of the Russian Federation
2015-2024

Central Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences
2009-2021

City Clinical Hospital
2021

Ild Care Foundation
2021

St. Antonius Ziekenhuis
2021

Restore America's Estuaries
2021

Central Research Institute
2019-2020

Russian Academy of Natural Sciences
2017

Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
2016

Реферат.Саркоидоз -системная патология иммунной системы, характеризующаяся образованием эпителиоидно-клеточных неказеифицирующихся гранулем и иммунным парадоксом, проявляющимся избыточной клеточной реакцией в местах проявления болезни при периферической анергии.Целью обзора является обобщение публикаций, отражающих сведения о заболеваемости, распространенности особенностях проявлений саркоидоза разных регионах Российской Федерации.Результаты их обсуждение.Анализ публикаций по эпидемиологии...

10.20969/vskm.2017.10(5).66-73 article RU The Bulletin of Contemporary Clinical Medicine 2017-05-01

Sarcoidosis is a multi-organ granulomatosis of unknown origin. Modern diagnostic methods allow detecting this disease at an early stage. The absence specific markers requires comprehensive approach to diagnosis based on comparison radiation, clinical, morphological and functional data. course sarcoidosis without damage the respiratory system presents significant difficulties. It extremely important understand time means starting Sarcoidosis’s treatment avoid initiation hormones cytostatics...

10.18093/0869-0189-2022-32-6-806-833 article EN cc-by-nc PULMONOLOGIYA 2022-12-11

The review analyzes publications devoted to the formation of phenotypes in sarcoidosis patients. It has been noted that there is a certain difficulty phenotyping disease can affect all human organs and systems. article demonstrates trend shift from Scadding radiographic stages intrathoracic sarcoidosis, based on radiography, high-resolution computed tomography. presents such parameters as organ damage, respiratory dysfunction, laboratory genetic data, treatment effects. authors note should...

10.58838/2075-1230-2024-102-3-84-94 article EN cc-by Tuberculosis and lung diseases 2024-07-05

ВЕСТНИК СОВРЕМЕННОЙ КЛИНИЧЕСКОЙ МЕДИЦИНЫ 2015 Том 8, вып. 1 ОбзОРЫ Х роническая обструктивная болезнь легких (ХОБЛ) -обычно предотвратимое и курабельное заболевание, характеризующееся постоянным ограничением воздушного потока, которое обычно прогрессирует связано с хронически повышенной воспалительной реакцией дыхательных путей в ответ на контакт вредными частицами газами.Обострения сопутствующие заболевания способствуют более тяжелому течению болезни [1, 2].В мировой клинической медицине...

10.20969/vskm.2015.8(1).62-69 article RU The Bulletin of Contemporary Clinical Medicine 2015-01-01

to compare respiratory function and laboratory data with the radiographic stages of intrathoracic sarcoidosis.Three hundred eleven patients (70.4% for women 29.6% men; mean age, 44.7±0.6 years) histologically verified sarcoidosis underwent X-ray computed tomography, spirography, estimation carbon monoxide diffusing capacity (DLCO), oxygen saturation, blood count serum total calcium test. The were assigned according as follows: 3.9% stage 0; 16.4% I; 65.3% II; 13.2% III; 1.3% IV, 12.9%...

10.17116/terarkh201587348-52 article RU Terapevticheskii arkhiv 2015-01-01

Представлен обзор литературы, посвященной становлению понятия «хроническая обструктивная болезнь легких» и ее компонентов ‒ хронического бронхита эмфиземы легких.

10.21292/2075-1230-2019-97-2-42-49 article RU cc-by Tuberculosis and lung diseases 2019-01-01

Sarcoidosis is epithelioid cell granulomatosis of unknown etiology. All the schemes its treatment are a recommendatory nature. Methotrexate (MTT) considered second-line drug in sarcoidosis. Methods . A retrospective observational study patients with progressive sarcoidosis (n = 104), treated MTT once week, was carried out. Clinical, laboratory, functional and radiation parameters were evaluated an interval 3 months ≤ 1 year. Results The use accompanied by improvement picture (64.1% end...

10.18093/0869-0189-2020-30-2-213-218 article EN cc-by PULMONOLOGIYA 2020-06-21

A literature review of the combination sarcoidosis and novel COVID-19 infection is presented. In mild forms sarcoidosis, without a decrease in lung function requiring immunosuppressive therapy, no additional risks have been identified context new pandemic. However, at stage diagnosis, one should be careful about changes CT scans patients with COVID-19, due to their similarity other conditions manifested by picture ‘frosted glass’, as case sarcoidosis. Immunosuppressive therapy for reduced...

10.33667/2078-5631-2020-19-65-69 article EN cc-by Medical alphabet 2020-11-02

Sarcoidosis is a systemic epithelioid cell granulomatosis of unknown origin. The specialized commission on pulmonology the Russian Ministry Health recommended creating register for sarcoidosis in beginning 2023. aim study was to assess main characteristics newly identified patients with according created Republic Tatarstan as pilot project. Methods. Information collected from 1996 Statistical processing 3,037 cases carried out using SPSS-18 program (IBM, USA). p -value < 0.05 considered...

10.18093/0869-0189-2024-34-4-487-497 article EN cc-by-nc PULMONOLOGIYA 2024-08-18

Abstract. Introduction. Sarcoidosis is the epithelioid cell granulomatosis, exact cause of which unknown. In 5-20% cases, pulmonary fibrosis develops that can adversely affect patient’s prognosis. Aim. Assessing clinical manifestations fibrosing sarcoidosis and comparing patients relevant to its various phenotypes, according computed tomography findings. Materials Methods. Findings in 81 were analyzed using high-resolution tomography. All examined by a pulmonologist. Along with assessment...

10.20969/vskm.2024.17(5).7-16 article EN The Bulletin of Contemporary Clinical Medicine 2024-10-01

The purpose of the study was to evaluate efficacy and safety systemic corticosteroids (SCS) in 245 patients with sarcoidosis a real clinical practice. Methods. This retrospective analysis outpatients pulmonary who visited pulmonologist 2000 2015. involved 166 females 79 males, mean age, 44.9 ± 0.8 years. diagnosis verified by biopsy 74.7% cases. Results. Prednisolone improved symptoms objective parameters 90.2% cases; 55.9% had relapse after treatment. Three"month treatment SCS not...

10.18093/0869-0189-2016-26-3-316-322 article EN PULMONOLOGIYA 2016-07-27

Antibacterial therapy is an essential component of treatment for bacterial respiratory infections. The last decade has seen increase in resistance pathogens to different classes antibiotics. purpose this review was analyze publications on azithromycin, a macrolide with both antibacterial and non-antibacterial properties. Studies conducted worldwide indicate heterogeneity the frequency azithromycin use it, but general, there values its minimum inhibitory concentration against which macrolides...

10.21518/ms2024-375 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2024-12-10

We presented a clinical case of 43-year woman with relapsing course sarcoidosis affecting the lungs and skin. The diagnosis was confirmed by biopsy. initial treatment included systemic corticosteroids which then were withdrawn due to insufficient efficacy subsequent administration methotrexate. This demonstrates personalized approach based on modern guidelines highlights difficulty develop standard therapeutic strategy for disease unknown etiology.

10.18093/0869-0189-2015-25-2-232-238 article EN PULMONOLOGIYA 2015-01-01

The objective: to compare the correct use of different types inhalers in patients with COPD and bronchial asthma. Subjects Methods. 100 108 BA were examined. Nine devices evaluated – a metered dose inhaler (MDI), Rapihaler, Respimat, Breezhaler, CDM, Turbuhaler, Genuair, Spiromax, Ellipta. application technique was assessed before patient read instructions governed by his intuition, after reading instructions, training inhalation investigating physician. Results. When used they managed them...

10.58838/2075-1230-2023-101-3-6-14 article EN cc-by Tuberculosis and lung diseases 2023-07-01

The treatment of sarcoidosis remains uncertain despite 70 years studies. conventional approach is to initiate corticosteroids in individuals who require treatment. However, date, there are no strict dosing regimens for systemic (SСS), and patients were treated with SСS develop relapses more frequently than those have not received these drugs. aim this work was evaluate the course outcomes pulmonary prescribed corticosteroids. Methods. study retrospective noninterventional. 493 (32.5%) 1,518...

10.18093/0869-0189-2023-33-5-634-644 article EN cc-by-nc PULMONOLOGIYA 2023-09-06

Introduction. During the COVID-19 pandemic, first experience was gained in managing patients with sarcoidosis face of a dangerous viral infection, combination two diseases and vaccination against COVID-19. Publications on this issue remain ambiguous, which made it relevant to assess management during pandemic features these patients. Aim. To condition who turned pulmonologist compare parameters had did not have COVID-19, mild severe course, as well evaluate effectiveness safety vaccination....

10.21518/ms2023-289 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2023-11-18

Aim. Content analysis and review of the works devoted to modern understanding idiopathic pulmonary fibrosis its treatment.Material methods.Publications national foreign authors were reviewed.Results discussion.Idiopathic is a special form chronic progressive fibrosing interstitial pneumonia unknown etiology that occurs predominantly in older people.It only affects lungs it associated with histological and/or X-ray pattern usual pneumonia.Prediction flow worse than some cancers.Diagnosis...

10.20969/vskm.2017.10(1).14-21 article EN The Bulletin of Contemporary Clinical Medicine 2017-02-01
Coming Soon ...